NM_005629.4:c.1768-3C>T

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2

The NM_005629.4(SLC6A8):​c.1768-3C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00588 in 1,198,729 control chromosomes in the GnomAD database, including 18 homozygotes. There are 2,195 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0043 ( 0 hom., 144 hem., cov: 23)
Exomes 𝑓: 0.0060 ( 18 hom. 2051 hem. )

Consequence

SLC6A8
NM_005629.4 splice_region, intron

Scores

2
Splicing: ADA: 0.07024
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 2.07

Publications

2 publications found
Variant links:
Genes affected
SLC6A8 (HGNC:11055): (solute carrier family 6 member 8) The protein encoded by this gene is a plasma membrane protein whose function is to transport creatine into and out of cells. Defects in this gene can result in X-linked creatine deficiency syndrome. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
SLC6A8 Gene-Disease associations (from GenCC):
  • creatine transporter deficiency
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, ClinGen, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.39).
BP6
Variant X-153695071-C-T is Benign according to our data. Variant chrX-153695071-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 212213.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00435 (490/112720) while in subpopulation AMR AF = 0.0078 (84/10773). AF 95% confidence interval is 0.00645. There are 0 homozygotes in GnomAd4. There are 144 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 144 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC6A8NM_005629.4 linkc.1768-3C>T splice_region_variant, intron_variant Intron 12 of 12 ENST00000253122.10 NP_005620.1 P48029-1X5D9C4
SLC6A8NM_001142805.2 linkc.1738-3C>T splice_region_variant, intron_variant Intron 12 of 12 NP_001136277.1 P48029Q59EV7
SLC6A8NM_001142806.1 linkc.1423-3C>T splice_region_variant, intron_variant Intron 12 of 12 NP_001136278.1 P48029-4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC6A8ENST00000253122.10 linkc.1768-3C>T splice_region_variant, intron_variant Intron 12 of 12 1 NM_005629.4 ENSP00000253122.5 P48029-1
SLC6A8ENST00000430077.6 linkc.1423-3C>T splice_region_variant, intron_variant Intron 12 of 12 2 ENSP00000403041.2 P48029-4
SLC6A8ENST00000485324.1 linkn.2075-3C>T splice_region_variant, intron_variant Intron 5 of 5 2

Frequencies

GnomAD3 genomes
AF:
0.00435
AC:
490
AN:
112668
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.000516
Gnomad AMI
AF:
0.00881
Gnomad AMR
AF:
0.00781
Gnomad ASJ
AF:
0.0139
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000725
Gnomad FIN
AF:
0.00112
Gnomad MID
AF:
0.0126
Gnomad NFE
AF:
0.00622
Gnomad OTH
AF:
0.00265
GnomAD2 exomes
AF:
0.00445
AC:
709
AN:
159238
AF XY:
0.00404
show subpopulations
Gnomad AFR exome
AF:
0.000445
Gnomad AMR exome
AF:
0.00249
Gnomad ASJ exome
AF:
0.0132
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00160
Gnomad NFE exome
AF:
0.00701
Gnomad OTH exome
AF:
0.00797
GnomAD4 exome
AF:
0.00604
AC:
6559
AN:
1086009
Hom.:
18
Cov.:
31
AF XY:
0.00579
AC XY:
2051
AN XY:
354315
show subpopulations
African (AFR)
AF:
0.000496
AC:
13
AN:
26187
American (AMR)
AF:
0.00298
AC:
102
AN:
34208
Ashkenazi Jewish (ASJ)
AF:
0.0139
AC:
265
AN:
19087
East Asian (EAS)
AF:
0.00
AC:
0
AN:
29767
South Asian (SAS)
AF:
0.000804
AC:
42
AN:
52239
European-Finnish (FIN)
AF:
0.00178
AC:
70
AN:
39380
Middle Eastern (MID)
AF:
0.0129
AC:
49
AN:
3792
European-Non Finnish (NFE)
AF:
0.00688
AC:
5753
AN:
835791
Other (OTH)
AF:
0.00582
AC:
265
AN:
45558
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
236
473
709
946
1182
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
208
416
624
832
1040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00435
AC:
490
AN:
112720
Hom.:
0
Cov.:
23
AF XY:
0.00413
AC XY:
144
AN XY:
34876
show subpopulations
African (AFR)
AF:
0.000515
AC:
16
AN:
31054
American (AMR)
AF:
0.00780
AC:
84
AN:
10773
Ashkenazi Jewish (ASJ)
AF:
0.0139
AC:
37
AN:
2660
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3563
South Asian (SAS)
AF:
0.000727
AC:
2
AN:
2750
European-Finnish (FIN)
AF:
0.00112
AC:
7
AN:
6277
Middle Eastern (MID)
AF:
0.0137
AC:
3
AN:
219
European-Non Finnish (NFE)
AF:
0.00622
AC:
331
AN:
53213
Other (OTH)
AF:
0.00261
AC:
4
AN:
1530
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
15
31
46
62
77
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00698
Hom.:
56
Bravo
AF:
0.00516

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Dec 31, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 03, 2017
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Creatine transporter deficiency Benign:2
May 18, 2022
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant has not been reported in the literature but is present in the Genome Aggregation Database (Highest reported MAF 0.7% (84/10760) including 39 hemizygotes (https://gnomad.broadinstitute.org/variant/X-153695071-C-T?dataset=gnomad_r3). This variant is present in ClinVar, with several labs classifying this variant as Benign (Variation ID:212213). Evolutionary conservation and computational predictive tools for this variant are limited or unavailable. This variant is an intronic variant with no predicted change in the amino acid sequence but may have an unknown effect on splicing. Computational prediction tools do not suggest that it alters splicing. However, further studies are needed to understand its impact. In summary, data on this variant suggests that this variant does not cause disease but requires further evidence. Therefore, this variant is classified as likely benign. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Creatine deficiency syndrome 1 Benign:1
Dec 20, 2019
Natera, Inc.
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

SLC6A8-related disorder Benign:1
May 15, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Inborn genetic diseases Benign:1
May 05, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.39
CADD
Benign
15
DANN
Benign
0.96
PhyloP100
2.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=95/5
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.070
dbscSNV1_RF
Benign
0.23
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs150207268; hg19: chrX-152960526; API